Top 20 of Disease Progression

Article title # Publications/# Citations

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

2005: European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group; AAllgeier; KBelanger; UBogdahn; AABrandes; JGCairncross; JCurschmann; ... EEisenhauer; BFisher; TGorlia; RCJanzer; DLacombe; SKLudwin; CMarosi; WPMason; ROMirimanoff; RStupp; MJTaphoorn; MJvan den Bent; MWeller;

1515

Inflammation and cancer.

2002 Dec 19-26: LMCoussens; ZWerb;

1512

MicroRNA signatures in human cancers.

2006: GACalin; CMCroce;

1055

Epithelial-mesenchymal transitions in tumour progression.

2002: JPThiery;

959

Prevention of HIV-1 infection with early antiretroviral therapy.

2011: HPTN 052 Study Team; DBurns; DCelentano; SChariyalertsak; YQChen; MSCohen; Gde Bruyn; VElharrar; ... JEron; SHEshleman; MEssex; TRFleming; JGallant; TGamble; SVGodbole; BGrinsztejn; JGHakim; DHavlir; IFHoffman; MCHosseinipour; NKumarasamy; JKumwenda; JMakhema; KHMayer; MMcCauley; SMehendale; LAMills; KNielsen-Saines; JHPilotto; EPiwowar-Manning; HRibaudo; ISanne; BRSantos; SSwindells; TETaha; LWang;

953

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

2001: ABajamonde; JBaselga; WEiermann; TFleming; HFuchs; BLeyland-Jones; LNorton; VPaton; ... MPegram; SShak; DJSlamon; JWolter;

912

Mild cognitive impairment: clinical characterization and outcome.

1999: RJIvnik; EKokmen; RCPetersen; GESmith; EGTangalos; SCWaring;

814

New functions for the matrix metalloproteinases in cancer progression.

2002: MEgeblad; ZWerb;

796

Sorafenib in advanced hepatocellular carcinoma.

2008: SHARP Investigators Study Group; JFBlanc; LBolondi; IBorbath; JBruix; ACde Oliveira; AForner; PRGalle; ... EGane; TGiannaris; TFGreten; DHäussinger; PHilgard; JMLlovet; VMazzaferro; MMoscovici; CPorta; JLRaoul; SRicci; ASantoro; MSchwartz; JFSeitz; MShan; DVoliotis; SZeuzem;

794

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

2009: SArbuck; JBogaerts; JDancey; LDodd; EAEisenhauer; RFord; SGwyther; RKaplan; ... DLacombe; MMooney; LRubinstein; DSargent; LHSchwartz; LShankar; PTherasse; JVerweij;

755

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

1999: MDalesandro; MAForman; JGhrayeb; MJKuroda; NLLetvin; MALifton; DCMontefiori; PRácz; ... KAReimann; EPRieber; SSantra; VGSasseville; BJScallon; JESchmitz; MASimón; KTenner-Racz;

685

Multi-Ethnic Study of Atherosclerosis: objectives and design.

2002: DEBild; DABluemke; GLBurke; RDetrano; AVDiez Roux; ARFolsom; PGreenland; DRJacob; ... RKronmal; KLiu; JCNelson; DO'Leary; MFSaad; SShea; MSzklo; RPTracy;

684

Nuclear factor-kappaB in cancer development and progression.

2006: MKarin;

600

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

2006: RAhmed; MAltfeld; JABrown; HMCoovadia; CLDay; CDePierres; JDuraiswamy; QEichbaum; ... GJFreeman; PJGoulder; DEKaufmann; PKiepiela; PKlenerman; AJLeslie; EWMackey; JDMiller; ZMncube; ESMoodley; SReddy; BDWalker; EJWherry; BZhu;

600

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

2006: JAbraham; JMBenito; MRBetts; MConnors; SCDe Rosa; PAGoepfert; RAKoup; MMLederman; ... SAMigueles; MCNason; MRoederer; SMWest;

582

TGFbeta in Cancer.

2008: JMassagué;

578

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

2007: CMBaum; RMBukowski; PWBycott; IChen; RAFiglin; TEHutson; STKim; MDMichaelson; ... RJMotzer; SNégrier; SOudard; ORixe; CSzczylik; PTomczak;

550

Fibroblasts in cancer.

2006: RKalluri; MZeisberg;

548

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

2004: DBets; HBleiberg; IChau; DCunningham; AHarstrick; YHumblet; DKhayat; MMueser; ... ASantoro; SSiena; EVan Cutsem; CVerslype;

547

Sorafenib in advanced clear-cell renal-cell carcinoma.

2007: Target Study Group; RMBukowski; CChevreau; TDemkow; AADesai; TEisen; BEscudier; SFreeman; ... MGore; TEHutson; SNégrier; SOudard; FRolland; BSchwartz; MShan; MSiebels; RSimantov; ESolska; WMStadler; CSzczylik;

542